Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors
Bladder Cancer, Breast Cancer, Colorectal Cancer
About this trial
This is an interventional supportive care trial for Bladder Cancer focused on measuring small cell lung cancer, non-small cell lung cancer, colon cancer, prostate cancer, breast cancer, male breast cancer, fatigue, lymphoma, ovarian epithelial cancer, bladder cancer, esophageal cancer
Eligibility Criteria
DISEASE CHARACTERISTICS: Survivor of breast, prostate, colon, lung, lymphoma, ovarian, bladder, or esophageal cancer with no evidence of disease At least moderate levels of fatigue and/or weakness Impaired mobility but ambulatory and medically able to participate in an exercise regimen No impaired knee flexion, defined as < 90º PATIENT CHARACTERISTICS: Folstein Mini-Mental Status Examination score ≥ 23 No extreme claustrophobia No diagnosed chronic fatigue syndrome/disorder No neurological impairments, including the following: Central nervous system disorder (e.g., multiple sclerosis or Parkinson's disease) Neurological insult (cerebrovascular attack) that manifests in a mobility disorder No myopathic disease (e.g., focal myopathy) that effects skeletal muscle structure/function No rheumatological disease that has an effect on muscle and/or mobility (e.g., polymyalgia rheumatica) PRIOR CONCURRENT THERAPY: More than 6 months since prior regular aerobic or resistance exercise Regular exercise defined as 2-3 times per week At least 6 months since prior cancer treatment (surgery, radiation, and/or chemotherapy ) No concurrent cancer-related treatment other than hormonal therapy
Sites / Locations
- Huntsman Cancer Institute at University of Utah